Nicholas Otte

2.0k total citations
8 papers, 558 citations indexed

About

Nicholas Otte is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Nicholas Otte has authored 8 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Biochemistry and 2 papers in Oncology. Recurrent topics in Nicholas Otte's work include Amino Acid Enzymes and Metabolism (7 papers), Epigenetics and DNA Methylation (6 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Nicholas Otte is often cited by papers focused on Amino Acid Enzymes and Metabolism (7 papers), Epigenetics and DNA Methylation (6 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Nicholas Otte collaborates with scholars based in Australia, United States and United Kingdom. Nicholas Otte's co-authors include Jeff Holst, Michelle van Geldermalsen, Qian Wang, John E.J. Rasko, Richard C. Koya, Nicholas A. Graham, Thomas G. Graeber, Begonya Comin-Anduix, Paul C. Tumeh and Aspram Minasyan and has published in prestigious journals such as Cancer Research, Biophysical Journal and International Journal of Cancer.

In The Last Decade

Nicholas Otte

8 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Otte Australia 6 407 238 191 183 97 8 558
Erica Pranzini Italy 14 373 0.9× 107 0.4× 33 0.2× 262 1.4× 61 0.6× 31 577
Shao Thing Teoh United States 11 341 0.8× 117 0.5× 29 0.2× 196 1.1× 110 1.1× 19 531
Yunkyung Heo South Korea 7 239 0.6× 58 0.2× 62 0.3× 203 1.1× 45 0.5× 13 420
Clint A. Stalnecker United States 7 284 0.7× 54 0.2× 43 0.2× 202 1.1× 22 0.2× 19 404
Lara Sala Danna Italy 3 341 0.8× 92 0.4× 52 0.3× 313 1.7× 25 0.3× 4 461
Lutfi Alfarsi United Kingdom 13 308 0.8× 98 0.4× 75 0.4× 237 1.3× 35 0.4× 19 440
Tereza Golias Slovakia 9 335 0.8× 54 0.2× 42 0.2× 216 1.2× 36 0.4× 11 455
Gopala K. Jarugumilli United States 9 454 1.1× 98 0.4× 52 0.3× 81 0.4× 27 0.3× 9 762
Radosław Polański United Kingdom 12 428 1.1× 186 0.8× 27 0.1× 268 1.5× 43 0.4× 14 602
Delaney K. Sullivan United States 9 347 0.9× 74 0.3× 34 0.2× 208 1.1× 50 0.5× 16 483

Countries citing papers authored by Nicholas Otte

Since Specialization
Citations

This map shows the geographic impact of Nicholas Otte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Otte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Otte more than expected).

Fields of papers citing papers by Nicholas Otte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Otte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Otte. The network helps show where Nicholas Otte may publish in the future.

Co-authorship network of co-authors of Nicholas Otte

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Otte. A scholar is included among the top collaborators of Nicholas Otte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Otte. Nicholas Otte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Otte, Nicholas, et al.. (2018). Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2. Frontiers in Chemistry. 6. 279–279. 21 indexed citations
2.
Marshall, Amy D., Michelle van Geldermalsen, Nicholas Otte, et al.. (2017). ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis. 6(7). e367–e367. 63 indexed citations
3.
Marshall, Amy D., Michelle van Geldermalsen, Nicholas Otte, et al.. (2016). LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma. International Journal of Cancer. 139(11). 2529–2539. 38 indexed citations
4.
Colas, Claire, Christof Grewer, Nicholas Otte, et al.. (2015). Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening. PLoS Computational Biology. 11(10). e1004477–e1004477. 61 indexed citations
5.
Colas, Claire, Armanda Gameiro, Thomas Albers, et al.. (2015). Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening. Biophysical Journal. 108(2). 54a–54a. 4 indexed citations
6.
Wang, Qian, Rae‐Anne Hardie, Andrew J. Hoy, et al.. (2015). Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth. QUT ePrints (Queensland University of Technology). 2 indexed citations
7.
Wang, Qian, Kimberley A. Beaumont, Nicholas Otte, et al.. (2014). Targeting glutamine transport to suppress melanoma cell growth. International Journal of Cancer. 135(5). 1060–1071. 182 indexed citations
8.
Koya, Richard C., Stephen Mok, Nicholas Otte, et al.. (2012). BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy. Cancer Research. 72(16). 3928–3937. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026